Strategic
Technology platforms create strategic opportunity.
PuroGen's patented systems represent a validated, regulation-ready platform with applications across multiple regulated industries.
Platform
A sustained record of invention. A validated portfolio.
PuroGen's technology platform originates from sustained invention in regulated sterilization and purification. SteriFlex®, TheBOX®, T10⁶®, and Reactive Oxygen™ are not products adapted for market — they are patented systems invented within the constraints of regulation.
This heritage produces a unique institutional asset: validated technology that is already proven, already documented, and already positioned for the regulatory shifts reshaping multiple industries.
Market Context
Regulatory tailwinds favor validated alternatives.
The FDA reclassified vaporized hydrogen peroxide sterilization to Category A in January 2024, formally recognizing VHP as an established sterilization method. Industry-wide pressure to transition away from ethylene oxide continues to accelerate.
These shifts are not predictions — they are documented regulatory actions. PuroGen's existing, validated systems are positioned at the intersection of this transition. The platform was designed for this standard before it existed.
Partnership Models
PuroGen engages through multiple structures, each calibrated to the depth and scope of the relationship.
Technology Licensing
Access to PuroGen's patented VHP sterilization and purification methods.
Co-Development
Joint development of next-generation systems for specific regulatory domains.
Strategic Collaboration
Broader partnership structures aligned with mutual institutional objectives.
OEM Partnership
Integrated manufacturing and validation programs under partner brands.
PuroGen welcomes dialogue with organizations that share our commitment to advancing sterilization science.
Begin a conversation